ÂÜÀòÂÒÂ×

Magnus Edlund is a seasoned professional with extensive experience in various sectors, including Industrial Goods, Retail Banking, and Pharmaceuticals. Currently serving as a Partner at Impilo since September 2017, Magnus also holds multiple board positions, including roles at Immedica Pharma AB, Lowenco A/S, VaccinDirekt, Mallax Pharmaceuticals AB, and tandlægen.dk. Previous experience includes a significant tenure at Orchid Orthopedic Solutions as a Member of the Board of Directors and positions at Altor Equity Partners as a Director and The Boston Consulting Group as a Project Leader. Magnus's expertise encompasses corporate strategy, strategic due diligence, product development organization, and customer strategy, underpinned by an academic background in Wireless Communications and Business Administration from The Royal Institute of Technology and UC San Diego.